The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage

CompletedOBSERVATIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

August 31, 2012

Conditions
Breast CancerPreneoplastic ConditionsDuctal Carcinoma in Situ
Interventions
DEVICE

Nipple aspirator

The subject will undergo nipple aspiration with a suction device designed to elicit fluid from the nipple.

DEVICE

Ductal lavage microcatheter

Upon completion of the nipple aspiration procedure, subjects will undergo a nipple block with local anesthesia. The duct will be lavaged with the ductal lavage microcatheter. Samples will be immediately processed for shipping to Covance for WGS. Subjects will be contacted 24 hours and again 2 weeks after the procedure to collect any untoward effects of participating in the study.

DEVICE

Blood draw

Blood will be drawn and immediately processed for shipping to Covance for WGS.

Trial Locations (1)

90403

Dr. Susan Love Research Foundation, Santa Monica

Sponsors
All Listed Sponsors
collaborator

Covance

INDUSTRY

collaborator

Illumina, Inc.

INDUSTRY

lead

Atossa Therapeutics, Inc.

INDUSTRY